AMENDMENT NO. 2 TO LICENSE AND DEVELOPMENT AGREEMENTLicense and Development Agreement • April 2nd, 2007 • Hana Biosciences Inc • Pharmaceutical preparations • Delaware
THIS AMENDMENT NO. 2 TO LICENSE AND DEVELOPMENT AGREEMENT (this “Amendment”), dated as of May 15, 2006, is entered into by and between NovaDel Pharma, Inc., a Delaware corporation (“NovaDel”), and Hana Biosciences, Inc., a Delaware corporation (the “Licensee”). NovaDel and Licensee each may be referred to herein individually as a “Party,” or collectively as the “Parties.”
AMENDMENT TO NO. 3 TO LICENSE AND DEVELOPMENT AGREEMENTLicense and Development Agreement • April 2nd, 2007 • Hana Biosciences Inc • Pharmaceutical preparations • Delaware
THIS AMENDMENT NO. 3 TO LICENSE AND DEVELOPMENT AGREEMENT (this “Amendment”), dated as of December 22, 2006, is entered into by and between NOVADEL PHARMA, INC., a Delaware corporation (“NovaDel”), and HANA BIOSCIENCES, INC., a Delaware corporation (the “Licensee”). NovaDel and Licensee each may be referred to herein individually as a “Party,” or collectively as the “Parties.”
Hana Biosciences, Inc. Stock Option Agreement (Non-Statutory)Stock Option Agreement • April 2nd, 2007 • Hana Biosciences Inc • Pharmaceutical preparations • Delaware
This Stock Option Agreement is made and entered into as of the [ ] day of [ ], 20[ ], between [ ] (“Employee”) and Hana Biosciences, Inc., a Delaware corporation (the “Company”).
